
Rich Durante
Advertisement
Articles by Rich Durante

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset
2
Nine European Drugmakers Warn the Continent Risks Losing the Pharma Investment Race: Report
3
CagriSema Tops Eli Lilly's Tirzepatide for Weight Loss in Late-Stage Diabetes Trial: Report
4
How Recent FDA Actions Impact Sponsors
5
